NCT07110103 2026-02-27
JACKPOT38
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06820762 2025-02-11
Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
The Second Affiliated Hospital of Dalian Medical University
Phase 2 Not yet recruiting
NCT06475209 2024-06-26
Adebrelimab + Apatinib in SCLC Maintenance Therapy
Tang-Du Hospital
Phase 2 Recruiting
NCT04677361 2021-10-08
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
Fox Chase Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT02990780 2021-04-28
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC
Shanghai Chest Hospital
Phase 3 Unknown
NCT03428607 2021-02-18
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]
Samsung Medical Center
Phase 2 Completed